Search

Your search keyword '"Mok, Kin Y."' showing total 258 results

Search Constraints

Start Over You searched for: Author "Mok, Kin Y." Remove constraint Author: "Mok, Kin Y."
258 results on '"Mok, Kin Y."'

Search Results

1. Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

2. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

3. Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

4. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease.

5. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy

6. Non-coding variability at the APOE locus contributes to the Alzheimer's risk.

7. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

8. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis

9. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

10. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

13. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification

14. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates

15. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

16. Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

18. A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

21. Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

23. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data

26. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2

28. Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology

30. The East Asian Parkinson Disease Genomics Consortium

31. A high‐performance biomarker panel for Alzheimer’s disease screening and staging identified by large‐scale plasma proteomic profiling

32. Identification of candidate parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets

33. Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers

35. Health comorbidities and cognitive abilities across the lifespan in Down syndrome

36. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease

37. Identification of sixteen novel candidate genes for late onset Parkinson's disease

38. Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging

39. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome

40. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

42. Evaluation of genetic risk for Alzheimer’s disease in the Hong Kong Chinese population

43. Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans

44. Common variation at the LRRK2 locus is associated with survival in the primary tauopathy progressive supranuclear palsy

45. Analysis of shared heritability in common disorders of the brain

47. Variation at the TRIM11 locus modifies Progressive Supranuclear Palsy phenotype

48. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer’s disease screening and staging.

49. Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome.

50. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability

Catalog

Books, media, physical & digital resources